TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Dating Sites: Best, Worst & Weirdest
STOCKS

Somaxon Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

  • By Seeking Alpha
  • Aug 7, 2012 7:51 PM EDT
One Short Seller's Take On Arena's Slow Belviq Launch
STOCKS

Transcept Wins Sleeping Pill Approval

  • By Adam Feuerstein
  • Nov 23, 2011 1:38 PM EST
Merck Sales of New Cancer Immunotherapy Top Street Estimates
STOCKS

Biotech Stock Mailbag: Somaxon, Transcept

  • By Adam Feuerstein
  • Oct 7, 2011 6:00 AM EDT
Merck Sales of New Cancer Immunotherapy Top Street Estimates
STOCKS

Biotech Stock Mailbag: Generex Bio

  • By Adam Feuerstein
  • Jun 24, 2011 7:00 AM EDT
Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed
STOCKS

Biotech Stock Mailbag: NuPathe

  • By Adam Feuerstein
  • Jun 17, 2011 6:53 AM EDT
First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
STOCKS

Biotech Stock Mailbag: Avanir Pharma

  • By Adam Feuerstein
  • Apr 1, 2011 7:39 AM EDT
Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies
STOCKS

Biotech Stock Mailbag: Cadence Pharma

  • By Adam Feuerstein
  • Mar 11, 2011 7:00 AM EST
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Mailbag: BIO CEO Wrap

  • By Adam Feuerstein
  • Feb 18, 2011 7:00 AM EST
Steve Rosenman Says Amarin Has Sticky Web Eyeballs!
STOCKS

Clinical Data: Bulls and Bears Round Two

  • By Adam Feuerstein
  • Jan 25, 2011 6:20 AM EST
MELA Sciences Is Doomed
STOCKS

Biotech Stock Mailbag: Aastrom BioSciences

  • By Adam Feuerstein
  • Nov 23, 2010 8:49 AM EST
A Letter to Cel-Sci's Geert and Max
STOCKS

Biotech Sector Weekly Rewind

  • By Adam Feuerstein
  • Oct 23, 2010 8:00 AM EDT
Vertex Cures Hard-to-Treat Hep C Patients
STOCKS

Biotech Stock Mailbag - Titan Pharma

  • By Adam Feuerstein
  • Oct 22, 2010 8:13 AM EDT
Lilly Sinks as Cholesterol-Lowering Pill Trial Shut Down
STOCKS

Somaxon Sleep Pill Faces Generic Challenge

  • By Adam Feuerstein
  • Oct 18, 2010 3:04 PM EDT
Pfizer to Buy King Pharma for $3.6B Cash
STOCKS

Biotech Sector Weekly Rewind

  • By Adam Feuerstein
  • Oct 9, 2010 8:00 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

China Sky One, Idenix: Volume Movers

  • By Robert Holmes
  • Sep 7, 2010 8:56 AM EDT
STOCKS

Somaxon: Readers Respond (Angrily)

  • By Adam Feuerstein
  • Sep 2, 2010 7:07 AM EDT
Merck to Trim Staff as Profit Meets Views
STOCKS

Somaxon: P&G Won't Wake Up Silenor Sales

  • By Adam Feuerstein
  • Aug 31, 2010 12:31 PM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

ICOP Digital, inTEST: Volume Movers

  • By Robert Holmes
  • Aug 12, 2010 8:11 AM EDT
Abbott Goes After Endometriosis
STOCKS

Biotech Stock Mailbag: Exact Sciences

  • By Adam Feuerstein
  • Jul 23, 2010 7:00 AM EDT
INVESTING

Westell Tech, Somaxon: Volume Movers

  • By Robert Holmes
  • Jul 22, 2010 7:56 AM EDT
Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

Biotech Stock Mailbag: Somaxon

  • By Adam Feuerstein
  • Jul 9, 2010 7:00 AM EDT
Dating Sites: Best, Worst & Weirdest
OPINION

Stock Offerings: EpiCept

  • By Robert Holmes
  • Jun 28, 2010 9:39 AM EDT
INVESTING

Biodel, Arena Pharma: Volume Movers

  • By Robert Holmes
  • Jun 28, 2010 8:00 AM EDT
Dating Sites: Best, Worst & Weirdest
OPINION

Top 10 Penny Stocks of 2010

  • By Robert Holmes
  • Jun 17, 2010 7:02 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Jones Soda, Somaxon: Early Volume Plays

  • By Robert Holmes
  • Mar 23, 2010 7:44 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.